IMM ImmuPharma plc

ImmuPharma PLC (AIM:IMM, FRA:25I) has signed up Kymos Group as its bioanalytical partner for diabetes drug Kapiglucagon. That completes the outsourced team needed to file for human trials in the US. ValiRx PLC (AIM:VAL, FRA:EAJF) is set to get a second European patent for its cancer-killing peptide from subsidiary Cytolytix. It's targeting triple negative breast cancer and is in talks with a major pharma company. Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF, FRA:TMU) has drilled some strong copper and silver hits at its Mushima North project in Zambia. Lab results are due in the coming weeks, with a resource estimate targeted by the end of the year. Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) has kept its 2026 gold production target after output jumped 18% quarter on quarter. Revenue, profit and earnings per share were all up sharply too. Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) will talk to shareholders after a third voted against its new equity pay plan. All resolutions still passed, and the CEO says big catalysts are coming over the next year. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.

Thermo Fisher Scientific (NYSE:TMO) has been selected by ImmuPharma as the key drug product and contract development manufacturer for its Kapiglucagon diabetes treatment program. The partnership covers development and manufacturing support for Kapiglucagon, an experimental therapy aimed at addressing diabetes. This agreement adds a new project to Thermo Fisher Scientific’s pharmaceutical services portfolio, focused on complex drug development work. For investors tracking Thermo Fisher...

Seeing Machines (AIM:SEE) has won a new driver monitoring contract with a European carmaker worth around $5 million in lifetime revenue, just as new EU safety rules make the technology mandatory on new vehicles. Production starts in 2028, with the system built into a rear-view mirror for easy deployment across multiple platforms. Frontier IP (LSE:FIPP) says portfolio company Cambridge Raman Imaging has secured a €400,000 European grant to scale up its AI-powered pharmaceutical quality control technology. The company has also appointed a China-based distributor with over 100 customers globally. ImmuPharma (AIM:IMM) has appointed Thermo Fisher Scientific to develop and manufacture the finished form of its experimental diabetes treatment Kapiglucagon. That completes the main manufacturing partnerships alongside Swiss group Bachem, which is handling the active ingredient. MP Evans (AIM:MPE) grew crude palm oil production 11% to 192,300 tonnes in the first half, supported by higher harvests across its Indonesian estates. Pricing also held firm at around $873 per tonne. Ariana Resources (AIM:AAU) says its Tavşan gold mine in Türkiye has completed its ramp-up and is now processing ore at the required rate of at least 4,000 tonnes a day. Gold recovery is tracking at around 70%. 88 Energy (AIM:88E) has moved its Augusta-1 Alaska well closer to a first-quarter 2027 spud after securing a rig and camp. Prospective resources at South Prudhoe have also been upgraded by 35%. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk. Read Proactive's Editorial Policy here: https://www.proactiveinvestors.co.uk/pages/editorialPolicy